Xenetic Biosciences Inc

Research Xenetic Biosciences Inc (XBIO) on Bullrun: market cap USD 6.53M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerXBIO
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 6.53M
• Financial periodFY2025
• RevenueUSD 2.98M
• Revenue growth19.0%
• Net income-USD 2.68M

Valuation Snapshot

latest market cap is USD 6.53M.

About Xenetic Biosciences Inc

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. Its DNase technology targets neutrophil extracellular traps (NETS), which are involved in cancer growth, metastasis, and progression, and contribute to immunotherapy, chemotherapy, and radiotherapy resistance. The company's product pipeline includes XBIO-015 for the treatment of pancreatic carcinoma and solid tumors; XBIO-020 for the treatment of solid tumors;

Frequently asked questions

What is Xenetic Biosciences Inc's market cap?

Xenetic Biosciences Inc's market capitalization is USD 6.53M.

What does Xenetic Biosciences Inc do?

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers.